Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
| 23.16 Delayed Data As of Dec 01 |  +1.96 / +9.25%Today’s Change | 20.67 Today|||52-Week Range 42.48 | -42.90% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Anzalone Christopher Richard Chief Executive Officer |  Sale | 5/03/2023 | 54,928 | $39.14 | $2.1M | -42.36% |
Myszkowski Kenneth Allen Chief Financial Officer | Sale | 12/29/2022 | 30,625 | $40.00 | $1.2M | -42.25% |
Anzalone Christopher Richard Chief Executive Officer | Sale | 5/04/2023 | 25,992 | $40.02 | $1.0M | -42.15% |
Anzalone Christopher Richard Chief Executive Officer | Sale | 5/04/2023 | 24,008 | $38.97 | $935.6K | -42.15% |
Anzalone Christopher Richard Chief Executive Officer | Sale | 9/18/2023 | 31,523 | $28.00 | $882.6K | -17.63% |
Anzalone Christopher Richard Chief Executive Officer | Sale | 9/18/2023 | 26,232 | $28.27 | $741.6K | -17.63% |
Anzalone Christopher Richard Chief Executive Officer | Sale | 10/25/2023 | 24,338 | $24.21 | $589.2K | -3.38% |
Myszkowski Kenneth Allen Chief Financial Officer | Sale | 6/27/2023 | 15,000 | $36.20 | $543.0K | -35.78% |
San Martin Javier Chief Medical Officer | Sale | 11/20/2023 | 14,758 | $28.73 | $424.0K | -19.83% |
Olukotun Adeoye Y Director | Sale | 3/03/2023 | 11,350 | $32.65 | $370.6K | -28.38% |
Page of 6